FMR1 CGG expansions: Prevalence and sex ratios

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 162, Issue 5, 2013, Pages 466-473

  Maenner, Matthew J ^a   Baker, Mei W ^b,c   Broman, Karl W ^c   Tian, Jianan ^d   Barnes, Janel K ^e   Atkins, Anne ^b,c   Mcpherson, Elizabeth ^f   Hong, Jinkuk ^a   Brilliant, Murray H ^f   Mailick, Marsha R ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b WISCONSIN STATE LABORATORY OF HYGIENE   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^d University of Wisconsin Madison   (United States)

^e LUTHER COLLEGE   (United States)

^f MARSHFIELD CLINIC   (United States)

Author keywords

FMR1; Fragile X; Gray zone; Premutation

Indexed keywords

ADULT; ARTICLE; FEMALE; FRAGILE X SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX RATIO;

ADULT; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE FREQUENCY; HUMANS; MALE; MUTATION; PREVALENCE; SEX RATIO; TRINUCLEOTIDE REPEATS; WISCONSIN;

EID: 84879397578     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32176     Document Type: Article

References (38)

1. Ashley-Koch AE, Robinson H, Glicksman AE, Nolin SL, Schwartz CE, Brown WT, Turner G, Sherman SL. 1998. Examination of factors associated with instability of the FMR1 CGG repeat. Am J Hum Genet 63:776-785.
2. Bailey DB, Raspa M, Olmsted M, Holiday DB. 2008. Co-occurring conditions associated with FMR1 gene variations: Findings from a National Parent Survey. Am J Med Genet Part A 146A(16):2060-2069.
3. Beckett L, Yu Q, Long AN. The numbers behind fragile X: Prevalence and economic impact. The National Fragile X Foundation Quarterly 2005. 21:18-21.
4. Berry-Kravis E, Goetz CG, Leehey MA, Hagerman RJ, Zhang L, Li L, Nguyen D, Hall DA, Tartaglia N, Cogswell J, Tassone F, Hagerman PJ. 2007. Neuropathic features in fragile X premutation carriers. Am J Med Genet Part A 143A:19-26.
5. Bretherick KL, Fluker MR, Robinson WP. 2005. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 117(4):376-382.
6. Brouwer JR, Willemsen R, Oostra BA. 2009. The FMR1 gene and fragile X-associated tremor/ataxia syndrome. Am J Med Genet Part B 150B:782-798.
7. Crawford DC, Meadows KL, Newman JL, Taft LF, Pettay DL, Gold LB, Hersey SJ, Hinkle EF, Stanfield ML, Holmgreen P. 1999. Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population. Am J Hum Genet 64:495-507.
8. Cornish KM, Hocking DR, Moss SA, Kogan CS. 2011. Selective executive markers of at-risk profiles associated with the fragile X premutation. Neurology 77(7):618-622.
9. Dombrowski C, Levesque S, Morel M, Rouillard P, Morgan K, Rousseau F. 2002. Premutation and intermediate-size FMR1 alleles in 10 572 males from the general population: Loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet 11:371.
10. Efron B, Tibshirani RJ. 1993. An introduction to the bootstrap. New York: Chapman & Hall/CRC.
11. Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, DHHS. 2009. NIH research plan on fragile X syndrome and associated disorders (NA). Washington, DC: U.S. Government Printing Office.
12. Fleiss JL. 1993. The statistical basis of meta-analysis. Stat Methods Med Res 2:121-145.
13. Hagerman PJ. 2008. The fragile X prevalence paradox. J Med Genet 45:498.
14. Hagerman PJ, Hagerman RJ. 2004. The fragile-X premutation: A maturing perspective. Am J Hum Genet 74:805-816.
15. Hall DA, Jacquemont S. 2010. The epidemiology of FXTAS. In: Tassone F, Berry-Kravis EM, editors. The fragile X-associated tremor ataxia syndrome (FXTAS). New York, NY: Springer New York. pp 17-30.
16. Hall DA, Berry-Kravis E, Zhang W, Tassone F, Spector E, Zerbe G, Hagerman PJ, Ouyang B, Leehey MA. 2011. FMR1 gray-zone alleles: Association with Parkinson's disease in women? Mov Disord 26(10):1900-1906.
17. Hall D, Tassone F, Klepitskaya O, Leehey M. 2012. Fragile X-associated tremor ataxia syndrome in FMR1 gray zone allele carriers. Mov Disord 27:297-301.
18. Hantash FM, Goos DM, Crossley B, Anderson B, Zhang K, Sun W, Strom CM. 2010. FMR1 premutation carrier frequency in patients undergoing routine population-based carrier screening: Insights into the prevalence of fragile X syndrome, fragile X-associated tremor/ataxia syndrome, and fragile X-associated primary ovarian insufficiency in the United States. Genet Med 13:39-45.
19. Hoffman GE, Le WW, Entezam A, Otsuka N, Tong Z-B, Nelson L, Flaws JA, McDonald JH, Jafar S, Usdin K. 2012. Ovarian abnormalities in a mouse model of fragile X primary ovarian insufficiency. J Histochem Cytochem 60:439-456.
20. Johannisson R, Rehder H, Wendt V, Schwinger E. 1987. Spermatogenesis in two patients with the fragile X syndrome. Hum Genet 76:141-147.
21. Kronquist KE, Sherman SL, Spector EB. Clinical significance of tri-nucleotide repeats in fragile X testing: A clarification of American College of Medical Genetics guidelines. Genet Med 2008. 10:845-847.
22. Loesch DZ, Huggins R, Petrovic V, Slater H. 1995. Expansion of the CGG repeat in fragile X in the FMR1 gene depends on the sex of the offspring. Am J Hum Genet 57:1408.
23. Loesch DZ, Bui QM, Huggins RM, Mitchell RJ, Hgerman RJ, Tassone F. 2007. Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats. J Med Genet 44:200-204.
24. Lu C, Lin L, Tan H, Wu H, Sherman SL, Gao F, Jin P, Chen D. 2012. Fragile X premutation RNA is sufficient to cause primary ovarian insufficiency in mice. Hum Mol Genet 21:5039-5047.
25. Maddalena A, Richards CS, McGinniss MJ, Brothman A, Desnick RJ, Grier RE, Hirsch B, Jacky P, McDowell GA, Popovich B. 2001. Technical standards and guidelines for fragile X: The first of a series of disease-specific supplements to the standards and guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Genet Med 3:200-205.
26. McCarty CA, Wilke RA, Giampietro PF, Wesbrook SD, Caldwell MD. 2005. Marshfield Clinic Personalized Medicine Research Project (PMRP): Design, methods and recruitment for a large population-based biobank. Personalized Med 2:49-79.
27. Nolin SL, Brown WT, Glicksman A, Houck GE Jr, Gargano AD, Sullivan A, Biancalana V, Bröndum-Nielsen K, Hjalgrim H, Holinski-Feder E. 2003. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 72:454-464.
28. Nolin SL, Lewis FA, Ye LL, Houck GE Jr, Glicksman AE, Limprasert P, Li SY, Zhong N, Ashley AE, Feingold E, Sherman SL, Brown WT. 1996. Familial transmission of the FMR1 CGG repeat. Am J Hum Genet 59:1252.
29. Rothman KJ. 2011. Episheet Online Tool. Available: http://krothman.hostbyet2.com/ [accessed 13 Dec 2012].
30. Rousseau F, Rouillard P, Morel ML, Khandjian EW, Morgan K. 1995. Prevalence of carriers of premutation-size alleles of the FMRI gene and implications for the population genetics of the fragile X syndrome. Am J Hum Genet 57:1006.
31. Rousseau F, Labelle Y, Bussières J, Lindsay C. 2011. The fragile X mental retardation syndrome 20 years after the FMR1 gene discovery: An expanding universe of knowledge. Clin Biochem Rev 32:135.
32. Seltzer MM, Baker MW, Hong J, Maenner M, Greenberg J, Mandel D. 2012. Prevalence of CGG expansions of the FMR1 gene in a US population-based sample. Am J Med Genet Part B 159B:589-597.
33. Song FJ, Barton P, Sleightholme V, Yao GL, Fry-Smith A. 2003. Screening for fragile X syndrome: A literature review and modelling study. Health Technol Assess 7(16):1-106.
34. Sullivan AK, Crawford DC, Scott EH, Leslie ML, Sherman SL. 2002. Paternally transmitted FMR1 alleles are less stable than maternally transmitted alleles in the common and intermediate size range. Am J Hum Genet 70:1532-1544.
35. Tassone F, Iong KP, Tong TH, Lo J, Gane LW, Berry-Kravis E, Nguyen D, Mu LY, Laffin J, Bailey DB, Hagerman RJ. 2012. FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Med 4(12):100.
36. Toledano-Alhadef H, Basel-Vanagaite L, Magal N, Davidov B, Ehrlich S, Drasinover V, Taub E, Halpern GJ, Ginott N, Shohat M. 2001. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. Am J Hum Genet 69:351-360.
37. Tzeng CC, Tsai LP, Hwu WL, Lin SJ, Chao MC, Jong YJ, Chu SY, Chao WC, Lu CL. 2005. Prevalence of the FMR1 mutation in Taiwan assessed by large-scale screening of newborn boys and analysis of DXS548-FRAXAC1 haplotype. Am J Med Genet Part A 133A:37-43.
38. United States Census Bureau. 2011. American Community Survey Available at: http://factfinder2.census.gov/faces/tableservices/jsf/pages/productview.xhtml?pid=ACS_11_1YR_B01001H&prodType=table (Accessed Jan 28, 2013).